Analysis of the Disulfide Bond Arrangement of the HIV-1 Envelope Protein CON-S gp140 ΔCFI Shows Variability in the V1 and V2 Regions

被引:37
|
作者
Go, Eden P. [1 ]
Zhang, Ying [1 ]
Menon, Sushma [1 ]
Desaire, Heather [1 ]
机构
[1] Univ Kansas, Dept Chem, Lawrence, KS 66047 USA
基金
美国国家卫生研究院;
关键词
disulfide; mass spectrometry; HIV-1; envelope protein; LC/ESI-FTICR; HUMAN-IMMUNODEFICIENCY-VIRUS; RECOMBINANT GLYCOPROTEIN-120 VACCINE; N-GLYCOSYLATION SITES; MASS-SPECTROMETRY; SUBTYPE-B; EXTRACELLULAR DOMAIN; SERUM-ALBUMIN; TYPE-1; GP120; ANTIBODIES; INFECTION;
D O I
10.1021/pr100764a
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Disulfide bonding of cysteines is one of the most important protein modifications, and it plays a key role in establishing/maintaining protein structures in biologically active forms. Therefore, the determination of disulfide bond arrangement is one important aspect to understanding the chemical structure of a protein and defining its functional domains. Herein, aiming to understand how the HIV-1 envelope protein's structure influences its immunogenicity, we used an MS-based approach, liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance (LC/ESI-FTICR) mass spectrometry, to determine the disulfide linkages on an oligomeric form of the group M consensus HIV-1 envelope protein (Env), CON-S gp140 Delta CFI. This protein has marked improvement in its immunogenicity compared to monomeric gp120 and wild-type forms of gp140 Envs. Our results demonstrate that the disulfide connectivity in the N-terminal region of CON-S gp140 Delta CFI is different from the disulfide bonding previously reported in the monomeric form of gp120 HIV-1 Env. Additionally, heterogeneity of the disulfide bonding was detected in this region. These data suggest that the V1/V2 region does not have a single, conserved disulfide bonding pattern and that variability could impact immunogenicity of expressed Envs.
引用
收藏
页码:578 / 591
页数:14
相关论文
共 49 条
  • [1] Antigenicity and immunogenicity of HIV-1 gp140 with different combinations of glycan mutation and V1/V2 region or V3 crown deletion
    Fu, Ming
    Hu, Kai
    Hu, Huimin
    Ni, Fengfeng
    Du, Tao
    Shattock, Robin J.
    Hu, Qinxue
    VACCINE, 2019, 37 (51) : 7501 - 7508
  • [2] ROLE OF THE V1, V2 DOMAIN OF HIV-1 ENVELOPE GP120 IN MACROPHAGE TROPISM
    KOITO, A
    LEVY, JA
    CHENGMAYER, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 32 - 32
  • [3] COMPLEX INTRAPATIENT SEQUENCE VARIATION IN THE V1 AND V2 HYPERVARIABLE REGIONS OF THE HIV-1 GP120 ENVELOPE SEQUENCE
    MARTINS, LP
    CHENCINER, N
    WAINHOBSON, S
    VIROLOGY, 1992, 191 (02) : 837 - 845
  • [4] Deglycosylation or Partial Removal of HIV-1 CN54 gp140 V1/V2 Domain Enhances Env-Specific T Cells
    Wan, Y.
    Liu, L.
    Xu, J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 140 - 140
  • [5] Deglycosylation or Partial Removal of HIV-1 CN54 gp140 V1/V2 Domain Enhances Env-Specific T Cells
    Wan, Yanmin
    Liu, Lianxing
    Wu, Lan
    Huang, Xianggang
    Ma, Liying
    Xu, Jianqing
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (06) : 607 - 617
  • [6] Structural Comparison of HIV-1 Envelope Spikes with and without the V1/V2 Loop
    Hu, Guiqing
    Liu, Jun
    Taylor, Kenneth A.
    Roux, Kenneth H.
    JOURNAL OF VIROLOGY, 2011, 85 (06) : 2741 - 2750
  • [7] A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies
    Doria-Rose, Nicole A.
    Georgiev, Ivelin
    O'Dell, Sijy
    Chuang, Gwo-Yu
    Staupe, Ryan P.
    McLellan, Jason S.
    Gorman, Jason
    Pancera, Marie
    Bonsignori, Mattia
    Haynes, Barton F.
    Burton, Dennis R.
    Koff, Wayne C.
    Kwong, Peter D.
    Mascola, John R.
    JOURNAL OF VIROLOGY, 2012, 86 (15) : 8319 - 8323
  • [8] Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120
    Doran, Rachel C.
    Morales, Javier F.
    To, Briana
    Morin, Trevor J.
    Theolis, Richard, Jr.
    O'Rourke, Sara M.
    Yu, Bin
    Mesa, Kathryn A.
    Berman, Phillip W.
    MOLECULAR IMMUNOLOGY, 2014, 62 (01) : 219 - 226
  • [9] ROLE OF THE HIV-1 GP120 DOMAINS V1, V2, AND V3 IN DETERMINING CYTOPATHOGENICITY
    GROENINK, M
    FOUCHIER, RAM
    BROERSEN, S
    BAKER, CH
    VANDERJAGT, RCM
    MIEDEMA, F
    HUISMAN, HG
    TERSMETTE, M
    SCHUITEMAKER, H
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 29 - 29
  • [10] MVA-expressed gp140 Boosts More Durable V1/V2 and gp120 Antibody Responses than gp120 Protein in Alum
    Shen, Xiaoying
    Basu, Rahul
    Kwa, Suefen
    Labranche, Celia
    Beaumont, David
    Ferrari, Guido
    Wyatt, Linda
    Moss, Bernard
    Montefiori, David
    Tomaras, Georgia
    Robinson, Harriet
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 59 - 59